Back to search

France· FR:60870205

VILDAGLIPTINE ZYDUS 50 mg, comprimé

A vildagliptin product containing vildagliptine, registered in France by ZYDUS FRANCE, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC A10BH02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVILDAGLIPTINE ZYDUS 50 mg, compriméATCA10BH02REGISTER NO.FR:60870205PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Vildagliptin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BH02 (vildagliptin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose

Vildagliptin · ATC A10BH02

16 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vildagliptin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.32 in France to $1.98 in Switzerland — a ×6.2 gap.

  • France: $0.32 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Vildagliptin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.98
  • IT Italy$1.0
  • FR France$0.32
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
VILDAGLIPTINE
Manufacturer
ZYDUS FRANCE
Country
France (FR)
ATC code
A10BH02
ATC class
Vildagliptin
Defined daily dose
0.1 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930244043
    plaquette(s) OPA : polyamide orienté aluminium PVC de 30 comprimé(s)
    EUR 4.22
  • cip13
    3400930244067
    plaquette(s) OPA : polyamide orienté aluminium PVC de 60 comprimé(s)
    EUR 8.25

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Vildagliptin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vildagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Melkart, Saxotin
  • Belgium · Vildagliptin Krka
  • Bulgaria · Глипвило, Далмевин
  • Cyprus · Aglimon, Dalmevin
  • Czechia · Alikval, Anvildis
  • Germany · Vildabetes, Vildagliptin Al
  • Denmark · Vildagliptin "a. E. Tiefenbacher", Vildagliptin "axunio"
  • Estonia · Dalmevin, Glypvilo
  • Spain · Vildagliptina, Vildagliptina Alter
  • Finland · Vildagliptin Krka, Vildagliptin Ratiopharm
  • United Kingdom (Northern Ireland) · Vildagliptin, Vildagliptin Accord-Uk
  • Greece · Dalmevin, Varbos
  • Croatia · Agnis, Dalmevin
  • Hungary · Agartha, Alikval
  • Ireland · Vildagliptin Krka
  • Iceland · Galvus, Jalra
  • Italy · Vildagliptin Accord, Vildagliptin Aurobindo
  • Liechtenstein · Galvus, Jalra
  • Lithuania · Dalmevin, Glypvilo
  • Latvia · Dalmevin, Glypvilo
  • Malta · Alikval, Dalmevin
  • Netherlands · Vilanov, Vildagliptine Accord
  • Norway · Galvus, Jalra
  • Poland · Anvildis, Diptivil
  • Portugal · Tutecvi, Vezagla
  • Romania · Agartha, Dalmevin
  • Sweden · Dalmevin, Kwikaton
  • Slovenia · Glypvilo
  • Slovakia · Anvildis, Dalmevin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fbcd7f24-3320-4bd2-951e-3c788fd1e75e
GET /v1/drugs/fbcd7f24-3320-4bd2-951e-3c788fd1e75e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60870205",
  "date_amm": "2021-12-22",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "VILDAGLIPTINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about vildagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.